Implication of species change of Nontuberculous Mycobacteria during or after treatment

17Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Co-existence or subsequent isolation of multiple nontuberculous mycobacteria (NTM) species in same patient has been reported. However, clinical significance of these observations is unclear. The aim of this study was to determine clinical implications of changes of NTM species during or after treatment in patients with NTM lung disease. Methods: Patients with NTM lung disease, who experienced changes of NTM species during treatment or within 2 years of treatment completion between January 1, 2009 and December 31, 2015, were included in the analysis. Demographic, clinical, microbiological, and radiographic data were reviewed and analyzed. Results: During the study period, 473 patients were newly diagnosed with NTM lung disease. Treatment was started in 164 patients (34.6%). Among these 164 patients, 16 experienced changes of NTM species during or within 2 years of treatment completion. Seven showed changes from M. avium complex (MAC) to M. abscessus subspecies abscessus (MAA) and five patients displayed changes from M. abscessus subspecies massiliense (MAM) to MAC. With isolation of new NTM species, 6 out of 7 patients with change from MAC to MAA reported worsening of symptoms, whereas none of the five patients with change from MAM to MAC reported worsening of symptoms. All MAA isolated during or after treatment for MAC lung diseases showed inducible resistance to clarithromycin. Conclusions: Change of NTM species may occur during or after treatment for NTM lung disease. Especially, changes from MAC to MAA is accompanied by symptomatic and radiographic worsening as well as inducible resistance to clarithromycin.

References Powered by Scopus

An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

5015Citations
N/AReaders
Get full text

Epidemiology of human pulmonary infection with nontuberculous mycobacteria a review

685Citations
N/AReaders
Get full text

A Novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of mycobacterium abscessus but is absent from mycobacterium chelonae

506Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016

39Citations
N/AReaders
Get full text

Nontuberculous mycobacterial lung diseases caused by mixed infection with mycobacterium avium complex and mycobacterium abscessus complex

29Citations
N/AReaders
Get full text

Species identification and antimicrobial susceptibility testing of non-tuberculous mycobacteria isolated in Chongqing, Southwest China

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lee, J. S., Lee, J. H., Yoon, S. H., Kim, T. S., Seong, M. W., Han, S. K., & Yim, J. J. (2017). Implication of species change of Nontuberculous Mycobacteria during or after treatment. BMC Pulmonary Medicine, 17(1). https://doi.org/10.1186/s12890-017-0539-7

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

63%

Professor / Associate Prof. 3

19%

Lecturer / Post doc 2

13%

Researcher 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

50%

Pharmacology, Toxicology and Pharmaceut... 3

19%

Immunology and Microbiology 3

19%

Veterinary Science and Veterinary Medic... 2

13%

Save time finding and organizing research with Mendeley

Sign up for free